# Shoulder Innovations, Inc. (SI)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/shoulder-innovations-inc/ JSON: https://steadybase.io/company/shoulder-innovations-inc.json Checked Nov 10, 2026. Latest filing read: Nov 5, 2026.

## Company

- Legal name: SHOULDER INNOVATIONS, INC.
- Ticker: SI (NYSE)
- SEC CIK: 0001699350
- Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
- Headquarters: Grand Rapids, MI
- Fiscal year ends: December 31
- SEC filer category: <br>Emerging growth company
- Website: shoulderinnovations.com
- LinkedIn: https://www.linkedin.com/company/shoulder-innovations
- Next earnings date: Nov 10, 2026

## Key facts

- Revenue: $47.3M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026). Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000011/0001699350-26-000011-index.html
- Operating income: -$26.3M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026). Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000011/0001699350-26-000011-index.html
- Net income: -$40.4M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026). Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000011/0001699350-26-000011-index.html
- SG&A: $54.8M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 10, 2026). Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000011/0001699350-26-000011-index.html
- Employees: 75 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000011/si-20251231.htm
- Shares outstanding: 20,922,587 as of Oct 29, 2026 (10-Q filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000064/0001699350-26-000064-index.html
- Auditor: Deloitte & Touche LLP, Grand Rapids, Michigan, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000011/si-20251231.htm

## Business

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Our ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1699350/000169935026000011/si-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $47.3M | -$26.3M | -$40.4M | $54.8M |
| Dec 31, 2024 | $31.6M | -$14.7M | -$15.6M | $34.5M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/shoulder-innovations-inc.json

## Officers and directors

- Robert Joseph Ball, CEO & Executive Chairman. LinkedIn: https://linkedin.com/in/rob-ball-7281aaa. Source: Form 4 filed Sep 14, 2026, https://www.sec.gov/Archives/edgar/data/1699350/000207066426000006/0002070664-26-000006-index.htm
- Jeffrey S. Points, Chief Financial Officer. LinkedIn: https://linkedin.com/in/jeff-points-09909115. Source: Form 4 filed Mar 17, 2026, https://www.sec.gov/Archives/edgar/data/1699350/000173141426000003/0001731414-26-000003-index.htm
- Jeffrey Points, Chief Financial Officer. Source: 10-K filed Mar 10, 2026, https://www.sec.gov/Archives/edgar/data/1699350/000169935026000011/si-20251231.htm
- Matthew Fraser Ahearn, Chief Operating Officer. Source: Form 4 filed Aug 18, 2026, https://www.sec.gov/Archives/edgar/data/1699350/000207058226000005/0002070582-26-000005-index.htm
- Matthew Ahearn, Chief Operating Officer. Source: 10-K filed Mar 10, 2026, https://www.sec.gov/Archives/edgar/data/1699350/000169935026000011/si-20251231.htm
- Jonathan E. Osborne, Chief Commercial Officer. Source: Form 3 filed Aug 10, 2026, https://www.sec.gov/Archives/edgar/data/1699350/000169935026000055/0001699350-26-000055-index.htm
- David Blue, Chief Customer Experience Officer. Source: 10-K filed Mar 10, 2026, https://www.sec.gov/Archives/edgar/data/1699350/000169935026000011/si-20251231.htm
- Jon Osborne, Senior Vice President of Commercial Development. Source: 10-K filed Mar 10, 2026, https://www.sec.gov/Archives/edgar/data/1699350/000169935026000011/si-20251231.htm
- Andrew Hykes, Board member (per proxy). Source: DEF 14A filed Apr 29, 2026, https://www.sec.gov/Archives/edgar/data/1699350/000169935026000026/si-20260428.htm
- David L. Blue, Named in proxy. Source: DEF 14A filed Apr 29, 2026, https://www.sec.gov/Archives/edgar/data/1699350/000169935026000026/si-20260428.htm
- Paul Buckman, Board member (per proxy). Source: DEF 14A filed Apr 29, 2026, https://www.sec.gov/Archives/edgar/data/1699350/000169935026000026/si-20260428.htm
- Richard J. Buchholz, Board member (per proxy). Source: DEF 14A filed Apr 29, 2026, https://www.sec.gov/Archives/edgar/data/1699350/000169935026000026/si-20260428.htm

## Recent 8-K events

- Nov 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000062/si-20261105.htm
- Oct 8, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000058/si-20261008.htm
- Aug 10, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000054/si-20260810.htm
- Aug 6, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000050/si-20260806.htm
- Jun 29, 2026: Item 1.01, Entry into a material definitive agreement; Item 1.02, Termination of a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000044/si-20260626.htm
- Jun 26, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000042/si-20260626.htm
- May 13, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000033/si-20260513.htm
- Apr 27, 2026: Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000021/si-20260427.htm
- Apr 14, 2026: Item 1.01, Entry into a material definitive agreement. Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000016/si-20260413.htm
- Mar 10, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000010/si-20260310.htm

## Insider trades (Form 4)

- Sep 14, 2026: Robert Joseph Ball (CEO & Executive Chairman) sold 10,175 shares, about $187,729. Source: https://www.sec.gov/Archives/edgar/data/1699350/000207066426000006/0002070664-26-000006-index.htm
- Aug 18, 2026: Matthew Fraser Ahearn (Chief Operating Officer) sold 22,500 shares, about $464,870. Source: https://www.sec.gov/Archives/edgar/data/1699350/000207058226000005/0002070582-26-000005-index.htm
- Jun 15, 2026: Matthew Fraser Ahearn (Chief Operating Officer) sold 20,000 shares, about $374,261. Source: https://www.sec.gov/Archives/edgar/data/1699350/000207058226000004/0002070582-26-000004-index.htm
- Mar 13, 2026: Robert Joseph Ball (CEO & Executive Chairman) bought 2,200 shares, about $33,396. Source: https://www.sec.gov/Archives/edgar/data/1699350/000207066426000004/0002070664-26-000004-index.htm
- Mar 13, 2026: Richard Buchholz (Director) bought 1,000 shares, about $14,840. Source: https://www.sec.gov/Archives/edgar/data/1699350/000173713326000001/0001737133-26-000001-index.htm
- Mar 13, 2026: Jeffrey S. Points (Chief Financial Officer) bought 2,000 shares, about $30,000. Source: https://www.sec.gov/Archives/edgar/data/1699350/000173141426000003/0001731414-26-000003-index.htm
- Dec 12, 2025: Jeffrey S. Points (Chief Financial Officer) bought 2,000 shares, about $29,632. Source: https://www.sec.gov/Archives/edgar/data/1699350/000162828025057080/0001628280-25-057080-index.htm
- Dec 12, 2025: Robert Joseph Ball (CEO & Executive Chairman) bought 7,200 shares, about $107,010. Source: https://www.sec.gov/Archives/edgar/data/1699350/000162828025057067/0001628280-25-057067-index.htm
- Sep 12, 2025: Jeffrey S. Points (CHIEF FINANCIAL OFFICER) bought 1,600 shares, about $25,072. Source: https://www.sec.gov/Archives/edgar/data/1699350/000149315225013488/0001493152-25-013488-index.htm
- Sep 12, 2025: Robert Joseph Ball (CEO & EXECUTIVE CHAIRMAN) bought 8,000 shares, about $122,740. Source: https://www.sec.gov/Archives/edgar/data/1699350/000149315225013475/0001493152-25-013475-index.htm
- Aug 1, 2025: Casey M. Tansey (Director) bought 40,000 shares, about $600,000. Source: https://www.sec.gov/Archives/edgar/data/1699350/000164117225022252/0001641172-25-022252-index.htm
- Aug 1, 2025: Jeffrey S. Points (CHIEF FINANCIAL OFFICER) bought 50 shares, about $750. Source: https://www.sec.gov/Archives/edgar/data/1699350/000164117225022250/0001641172-25-022250-index.htm
- Aug 1, 2025: Geoffrey B. Pardo (Director) bought 100,000 shares, about $1.5M. Source: https://www.sec.gov/Archives/edgar/data/1699350/000164117225022249/0001641172-25-022249-index.htm
- Aug 1, 2025: Michael A. Carusi (Director) bought 266,666 shares, about $4.0M. Source: https://www.sec.gov/Archives/edgar/data/1699350/000164117225022246/0001641172-25-022246-index.htm
- Aug 1, 2025: Richard Buchholz (Director) bought 5,000 shares, about $75,000. Source: https://www.sec.gov/Archives/edgar/data/1699350/000164117225022244/0001641172-25-022244-index.htm

## What management said

- "Our third quarter results reflect the consistency of our commercial model, as we added new surgeons ahead of plan, grew volume within our existing customer base, and kept our product roadmap moving" Rob Ball, CEO of Shoulder Innovations (8-K filed Nov 5, 2026). Source: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000062/ex-991earningsreleaseq32026.htm

## Latest filings

- 8-K filed Oct 8, 2026: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000058/si-20261008.htm
- 10-K filed Mar 10, 2026: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000011/si-20251231.htm
- 10-Q filed Aug 6, 2026: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000052/si-20260630.htm
- DEF 14A filed Apr 29, 2026: https://www.sec.gov/Archives/edgar/data/1699350/000169935026000026/si-20260428.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/